Cancer‐associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti‐angiogenic therapy
- 9 June 2021
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 129 (1), 80-92
- https://doi.org/10.1111/bju.15506
Abstract
Objectives To investigate the role of cancer-associated fibroblasts (CAFs) in clear cell renal cell carcinoma (ccRCC) with respect to tumor aggressiveness, metastasis development and resistance to antiangiogenic therapy (VEGFR-tyrosine kinase inhibitors, VEGFR-TKI). Methods Our study involved tissue samples from three distinct and independent cohorts of patients with ccRCC. The presence of CAFs and tumor lymphangiogenesis was investigated respectively by transcriptional signatures and then correlated with tumor development and prognosis. The effect of these CAFs on tumor cell migration and VEGFR-TKI resistance was analyzed on co-cultures of ccRCC cells with CAFs. Results Results from our cohorts and from in silico investigations showed that VEGFR-TKI significantly increase the number of CAFs in tumors. In the same populations of ccRCC patients, the proportion of intra-tumoral CAFs correlated to shorter disease-free and overall survival. The presence of CAFs was also correlated with lymphangiogenesis and lymph node metastasis. CAFs increased the migration and decrease the VEGFR-TKI-dependent cytotoxic effect of tumor cells. Conclusions Our results showed that VEGFR-TKI promote the development of CAFs, and CAFs favor tumor aggressiveness, metastatic dissemination and resistance to treatment in ccRCC. CAFs could represent a new therapeutic target to fight resistance to treatment of ccRCC. Targeting CAF and immunotherapies combination are emerging as efficient treatments in many types of solid tumors. Our results highlight their relevance in ccRCCs.Keywords
Funding Information
- Fondation de France
This publication has 41 references indexed in Scilit:
- Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in MelanomaClinical Cancer Research, 2012
- Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblastsProceedings of the National Academy of Sciences of the United States of America, 2010
- Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsClinical Cancer Research, 2009
- PDGF-C Induces Maturation of Blood Vessels in a Model of Glioblastoma and Attenuates the Response to Anti-VEGF TreatmentPLOS ONE, 2009
- PD-1 Ligand Expression by Human Colonic Myofibroblasts/Fibroblasts Regulates CD4+ T-Cell ActivityGastroenterology, 2008
- Sunitinib versus Interferon Alfa in Metastatic Renal-Cell CarcinomaThe New England Journal of Medicine, 2007
- Functional and molecular mapping of uncoupling between vascular permeability and loss of vascular maturation in ovarian carcinoma xenografts: The role of stroma cells in tumor angiogenesisInternational Journal of Cancer, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Angiogenesis gene expression profiling in xenograft models to study cellular interactionsExperimental Cell Research, 2004
- Molecular characterization of lymphatic endothelial cellsProceedings of the National Academy of Sciences of the United States of America, 2002